1. Home
  2. WGSWW vs VLYPO Comparison

WGSWW vs VLYPO Comparison

Compare WGSWW & VLYPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGSWW
  • VLYPO
  • Stock Information
  • Founded
  • WGSWW 2017
  • VLYPO N/A
  • Country
  • WGSWW United States
  • VLYPO United States
  • Employees
  • WGSWW 1000
  • VLYPO 3732
  • Industry
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • VLYPO Major Banks
  • Sector
  • WGSWW Technology
  • VLYPO Finance
  • Exchange
  • WGSWW Nasdaq
  • VLYPO Nasdaq
  • Market Cap
  • WGSWW N/A
  • VLYPO N/A
  • IPO Year
  • WGSWW N/A
  • VLYPO N/A
  • Fundamental
  • Price
  • WGSWW $0.03
  • VLYPO $24.83
  • Analyst Decision
  • WGSWW
  • VLYPO
  • Analyst Count
  • WGSWW 0
  • VLYPO 0
  • Target Price
  • WGSWW N/A
  • VLYPO N/A
  • AVG Volume (30 Days)
  • WGSWW 36.6K
  • VLYPO N/A
  • Earning Date
  • WGSWW 02-18-2025
  • VLYPO N/A
  • Dividend Yield
  • WGSWW N/A
  • VLYPO N/A
  • EPS Growth
  • WGSWW N/A
  • VLYPO N/A
  • EPS
  • WGSWW N/A
  • VLYPO N/A
  • Revenue
  • WGSWW $305,450,000.00
  • VLYPO N/A
  • Revenue This Year
  • WGSWW N/A
  • VLYPO N/A
  • Revenue Next Year
  • WGSWW N/A
  • VLYPO N/A
  • P/E Ratio
  • WGSWW N/A
  • VLYPO N/A
  • Revenue Growth
  • WGSWW 50.79
  • VLYPO N/A
  • 52 Week Low
  • WGSWW $0.17
  • VLYPO N/A
  • 52 Week High
  • WGSWW $0.21
  • VLYPO N/A
  • Technical
  • Relative Strength Index (RSI)
  • WGSWW N/A
  • VLYPO 48.18
  • Support Level
  • WGSWW N/A
  • VLYPO $24.96
  • Resistance Level
  • WGSWW N/A
  • VLYPO $24.97
  • Average True Range (ATR)
  • WGSWW 0.00
  • VLYPO 0.18
  • MACD
  • WGSWW 0.00
  • VLYPO -0.05
  • Stochastic Oscillator
  • WGSWW 0.00
  • VLYPO 54.35

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About VLYPO Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

Share on Social Networks: